Health24.com | PODCAST | Growing up in a time of HIV: ‘The babies we saved decades ago are now contracting the virus in their teens’

The information on Health24 is for educational purposes only, and is not intended as medical advice, diagnosis or treatment. If you are experiencing symptoms or need health advice, please consult a healthcare professional. See additional information.

Share Button

Health24.com | Even dolphins are threatened by antibiotic-resistant ‘superbugs’

Scientists have found one more way Flipper is a lot like people: The sharp rise in antibiotic resistance affecting humans is also happening to dolphins.

The discovery stems from a 13-year study of bottlenose dolphins in Florida’s Indian River Lagoon.

A ‘toxic cocktail’ of chemicals

“We’ve been able to provide a large database of information in order to continue learning from these impressive animals,” said Gregory Bossart, senior vice president and chief veterinary officer at the Georgia Aquarium, one of four partners in the new study.

The research, published in the journal Aquatic Mammals, follows a report last week that bottlenose dolphins in the English Channel harbour “a toxic cocktail” of chemicals, including some that have been banned for decades.

For the latest study, the researchers analysed antibiotic resistance in 733 samples of bacteria collected between 2003 and 2015 from 171 bottlenose dolphins in the lagoon on Florida’s eastern coast. Some of the bacteria are also a threat to humans.

In all, over 88% were resistant to at least one antibiotic, the researchers found. Resistance was highest to erythromycin (nearly 92%), followed by ampicillin (77%) and cephalothin (about 62%).

Similar to trends in people, resistance to ciprofloxacin among E. coli samples more than doubled during the study.

And rates of resistance in Pseudomonas aeruginosa – a cause of respiratory and urinary infections in people – were the highest recorded for any organism and increased over the period, the findings showed.

One of the biggest public health challenges

The researchers also reported significant increases in antibiotic resistance in Vibrio alginolyticus, a common marine bacterium that causes serious seafood poisoning.

Lead author Adam Schaefer said, “In 2009, we reported a high prevalence of antibiotic resistance in wild dolphins, which was unexpected. Since then, we have been tracking changes over time and have found a significant increase in antibiotic resistance in isolates from these animals.”

Schaefer is an epidemiologist at Florida Atlantic University (FAU) Harbor Branch Oceanographic Institute, in Boca Raton.

“Based on our findings, it is likely that these isolates from dolphins originated from a source where antibiotics are regularly used, potentially entering the marine environment through human activities or discharges from terrestrial sources,” he added in a FAU news release.

Antibiotic resistance is one of the biggest public health challenges worldwide. At least two million people a year in the United States get an antibiotic-resistant infection, and at least 23 000 of them die.

Few studies have examined long-term trends in antibiotic resistance in wildlife, according to the researchers.

In a separate study, published in the journal Scientific Reports, Belgian and French scientists reported high concentrations of industrial fluids and mercury in dolphins found off the northwest coast of France.

Many of the chemicals, including PCBs, have been banned since the 1970s and 1980s, but persist in the environment, where they can pass through the food chain, the researchers said.

Image credit: iStock

Share Button

Can you turn around the health of an entire town?

Three years on, how is a project aimed at transforming the health of people in Fleetwood faring?

Share Button

Microbiome may be involved in mechanisms related to muscle strength in older adults

A novel new study suggests that the gut microbiome has a role in mechanisms related to muscle strength in older adults. The work, led by researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts, is available as a pre-proof in advance of print in Experimental Gerontology.

The gut-muscle axis, or the relationship between gut microbiota and muscle mass and physical function, has gained momentum as a research topic in the last few years as studies have established that gut microbiota influences many aspects of health. While researchers have begun exploring the connection between the gut microbiome, muscle, and physical function in mice and younger adults, few studies have been conducted with older adults.

To gain insight into this population, the researchers compared bacteria from the gut microbiomes of 18 older adults with high-physical function and a favorable body composition (higher percentage of lean mass, lower percentage of fat mass) with 11 older adults with low-physical function and a less favorable body composition. The small study identified differences in the bacterial profiles between the two groups.

Similar bacterial differences were present when mice were colonized with fecal samples from the two human groups, and grip strength was increased in mice colonized with samples from the high-functioning older adults, suggesting a role for the gut microbiome in mechanisms related to muscle strength in older adults.

Specifically, when compared to the low-functioning older adult group, the researchers found higher levels of Prevotellaceae, Prevotella, Barnesiella, and Barnesiella intestinihominis — all potentially good bacteria — in the high-functioning older adults and in the mice that were colonized with fecal samples from the high-functioning older adults.

No significant differences in body composition or endurance capacity were observed in the colonized mice; however, the researchers note that the length of the intervention period was short and these data may warrant further study.

“While we were surprised that we didn’t identify a role for the gut microbiome on the maintenance of body composition, with these results we now start to understand the role of gut bacteria in the maintenance of muscle strength in older adults,” said Michael Lustgarten, last and corresponding author on the study and a researcher in the Nutrition, Exercise Physiology & Sarcopenia (NEPS) Laboratory at the HNRCA. “For example, if we were to conduct an intervention to increase Prevotella levels in the gut microbiome, we would expect to see an increase in muscle strength if these bacteria are involved. Prevotella’s role in the maintenance of muscle strength in older adults is one area we expect to continue to explore.”

“As we age, body composition, muscle strength, and lean mass all decrease,” said first author Roger Fielding, director of the NEPS Laboratory at the HNRCA. “Identifying differences in bacteria present in the high-functioning and low-functioning groups in this study moves us toward a fuller understanding of both the gut microbiome and healthy aging.”

For the study, the researchers measured lower extremity function, mobility, and strength in the sedentary older adult group (ages 70-85) at the first and one-month study visits. In the mice, they measured body composition with quantitative magnetic resonance imaging, and grip strength and treadmill endurance capacity to test physical function. Fecal samples from the older adults were transplanted into young, gender-matched germ-free mice. Four weeks after fecal transfer, the researchers measured body composition, physical function, and gut microbiome in the 18 mice colonized with fecal samples from the high-functioning human group and the 18 mice colonized with fecal samples from the low-functioning human group.

The authors note the small sample size and brief time period as potential study limitations.

Story Source:

Materials provided by Tufts University, Health Sciences Campus. Note: Content may be edited for style and length.

Share Button

Fruit flies’ microbiomes shape their evolution

The expression “you are what you eat” has taken on new meaning. In an experiment in fruit flies, or Drosophila melanogaster, researchers at the University of Pennsylvania have found that adding different species of microbes to the flies’ food caused populations to diverge genetically, racking up significant genomic changes in just five generations.

“Our work is very suggestive that microbial community composition drives, at least in part, how the organisms in which they live are evolving,” says Paul Schmidt, a biologist at Penn and senior author on the work, which appears in the journal PNAS. “The fact that we can see this effect in experiments done over such a short time scale suggests that the magnitude of the fitness effects the microbes have is incredible.”

Unlike a laboratory experiment, where every possible aspect of the environment is controlled, from the genetics of the flies themselves to the temperature and diet, in order to magnify differences between treatments this set of experiments took place outdoors, at Pennovation Works on Penn’s campus. The setting more closely mirrors nature, subject to weather, seasonal changes, even the odd spider or fleck of dirt intruding in the enclosures.

The fact that, despite the potential influences of these outside factors, the researchers still found the microbiome shifts to have a significant effect on the genomes of fly populations, makes the finding even more compelling, Schmidt says.

“I think it’s fair to say we preserved as much ecological realism as we could at the expense of detecting large effects,” he says. “We just shifted the relative abundance of these microbes in the flies’ diet, and that was enough to see an effect.”

Schmidt and postdoctoral fellow Seth Rudman, the lead author on the paper, took advantage of the fact that flies have relatively simple microbiome communities compared to other organisms, such as humans.

“If you do a survey of a mammalian microbiome, many of the bacteria you find in the gut are unknown,” says Rudman. “But that’s not the case with flies. It just happens that Drosophila have only about 100 species in their microbiome community.”

Other benefits of fruit flies for this type of study include their short generation time — one can study several generations in a matter of months — and the fact that they can be reared to extremely high population sizes. In this case, that meant hundreds of thousands of flies in each experiment.

From earlier work, scientists had an inkling that the microbiome was linked to changes in the fitness of the fly. Flies from more northern latitudes tend to have more Lactobacillus bacteria as part of their microbiome, and also live longer, have fewer eggs and are more tolerant to stress. More southerly populations, on the other hand, which tend to have more of the bacteria Acetobacter, had shorter lifespans, more eggs, and were less stress-tolerant. Work in the lab showed that exposing flies to these two types of bacteria elicited these same traits.

But could the microbes drive the evolution of whole populations of flies? To test that, Schmidt, Rudman, and colleagues designed an experimental setup to manipulate the flies’ microbiomes. They introduced a thousand flies into each of several outdoor mesh enclosures, 2 cubic meters in size and adorned with groundcover and a peach tree. They varied the food in some of the enclosures, supplementing it with either Acetobacter or Lactobacillus.

The researchers confirmed that the feeding altered the microbiomes of the flies, though just slightly. That was enough, however, to affect their genes. Comparing the genomes of the flies at the start of the study to the conclusion, after five generations, the team could pick out distinct changes in the frequency of certain alleles — one variant of a gene — that were consistent with what has been seen in natural populations of flies.

“We found that the allele that was more common in the Lactobacillus solution cages was also the allele that’s more common in the north, where Lactobacillus itself is more common,” says Rudman. “And the allele that was more common in the Acetobacter cages was also the allele that is more common in the south, where Acetobacter is more common.”

To the researchers, that finding hammered home the significance of the microbes’ influence.

“The bottom line is, microbes drive rapid adaptation,” Schmidt says.

Whether that effect translates to humans and other animals is a matter for further study, the authors say, but numerous studies have underscored the potent effect of the microbiome.

In future work, the researchers will be flipping the script, testing to see whether changes in the flies’ genetic profiles influence which microbes can gain a foothold in their microbiomes. And they’ll also probe more deeply into determining precisely how the changing microbiome affects its host.

Share Button

Electronic nose can sniff out which lung cancer patients will respond to immunotherapy

An electronic nose that detects chemicals in the breath of lung cancer patients can identify with 85% accuracy those who will or will not respond to immunotherapy, according to new research published in the leading cancer journal Annals of Oncology [1] today (Wednesday).

The results of the first study to investigate this show that the eNose is more accurate than the current gold standard of immunohistochemistry (IHC) for selecting patients who will respond to anti-PD-1 immunotherapies such as nivolumab or pembrolizumab. IHC involves testing tissue samples for the presence of the protein called programmed death ligand 1 (PD-L1), which is the target for anti-PD 1 therapies, but it is invasive and takes time to obtain results.

Professor Michel van den Heuvel, professor of thoracic oncology at the Radboud University Medical Centre (Nijmegen,The Netherlands), who led the research, said: “The introduction of immunotherapy has dramatically improved the treatment of advanced stage non-small cell lung cancer but unfortunately it is only effective in a subset of patients, which was about 20% when we started the study. Currently, there is no test available that can accurately predict who will benefit from this treatment, apart from PD-L1 testing by immunohistochemistry. This is today’s biomarker of choice, despite its analytic and predictive limitations, when making clinical decisions about whether or not to treat a patient with immunotherapy.”

Ms Rianne de Vries, a PhD student in the department of respiratory medicine at Amsterdam University Medical Centres (The Netherlands), who is joint first author of the study, said: “We hypothesised that exhaled breath analysis using eNose technology might be a non-invasive and rapid alternative to the current standard and would enable doctors to avoid treating patients with an immunotherapy to which they would not respond.”

The eNose is a small device [2] that contains sensors to detect chemicals called volatile organic compounds (VOCs), which are present in about one per cent of our exhaled breath. The rest of our breath mainly consists of nitrogen, oxygen, carbon dioxide and water. The researchers thought that the mix of VOCs in the breath of patients with advanced non-small cell lung cancer (NSCLC) might indicate whether or not the patient would respond to anti-PD1 therapy; VOCs can vary depending on metabolic processes that occur in the whole body or in parts of it, such as the lungs.

Ms de Vries, who is also chief operating officer of Breathomix, which is currently producing the eNose, continued: “When using the eNose, the patient takes a deep breath, holds it for five seconds and then slowly exhales into the device. The eNose sensors respond to the complete mixture of VOCs in the exhaled breath; each sensor has its highest sensitivity to a different group of molecules. The sensor readings are sent directly to and stored at an online server for real-time processing of the data and for ambient air correction because the air that you exhale is influenced by the air that you inhale. The measurement takes less than a minute, and the results are compared to an online database where machine-learning algorithms immediately identify whether or not the patient is likely to respond to anti-PD1 therapy.”

Between March 2016 and February 2018, the researchers at The Netherlands Cancer Institute, Amsterdam, recruited 143 patients with advanced NSCLC. They used the eNose to take the breath profiles of the patients two weeks before they started treatment with nivolumab or pembrolizumab, and after three months they used standard criteria (Response Evaluation Criteria of Solid Tumours, RECIST) to assess whether the patients were responding to the treatment nor not. Results from the first 92 patients (who started treatment between March 2016 and February 2017) were validated by the results from the remaining 51 patients (who started treatment after April 2017).

The other first author of the study, Dr Mirte Muller, a PhD student in the department of thoracic oncology at The Netherlands Cancer Institute, said: “We found that before the start of treatment with immunotherapy, the eNose analysis of exhaled breath from the patients with non-small cell lung cancer could distinguish between responders and non-responders with an accuracy of 85%.

“Our findings show that breath analysis by eNose can potentially avoid application of ineffective treatment to patients that are identified by eNose as being non-responders to immunotherapy, which in our study was 24% of the patients. This means that in 24% of NSCLC patients this treatment could be avoided, without denying anyone effective treatment.

“ENose technology is cheap compared to other available medical technologies and diagnostic tests and biomarkers. The eNose qualifies as a non-invasive and rapid point-of-care test that provides feedback within seconds in the doctor’s office. Our results form a solid base for taking the next step to validate these findings in a large prospective multi-centre study.”

Although immunotherapy tends to have fewer side effects than chemotherapy, with fatigue being the most common, it can trigger more serious side effects in about 10% of patients. Organs such as the lungs, liver and bowel can become inflamed when the body’s immune system starts to attack its own cells. By correctly identifying patients who will not respond to immunotherapy, side effects related to the treatment can be avoided.

Prof van den Heuvel concluded: “We are convinced that this study merely scratches the surface. It represents the first introduction of modern precision medicine, namely that molecular fingerprints can be easily obtained and quickly analysed on the spot. This truly offers new possibilities for the individual patient and the doctor. The power of this eNose system is that it has been properly validated, both technically and clinically, which is essential. We believe that analysis of exhaled breath is going to become an important diagnostic tool and will guide future treatment in oncology as well as in many other diseases.”

Share Button

Inquiry into safety and wellbeing concerns at two hospitals

It follows problems at the new children’s hospital in Edinburgh and the Queen Elizabeth University Hospital in Glasgow.

Share Button

Soot pollution particles ‘cross the placenta’

Particles of black carbon pollution can cross to the fetal side of the placenta, a study finds.

Share Button

Health24.com | WATCH: Science has discovered that cheese is as addictive as cocaine

With so many options to choose from, it’s no surprise that cheese is a popular additive to certain meals and a scrumptious snack choice for parties.

Cheese was discovered over 4000 years ago, by accident, and it’s been said that cheese can give you bad breath and even cause nightmares.

Scientists have now discovered that cheese, as delicious as what it is, can be as addictive as cocaine. 

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | WATCH – Why loud chewing has kept this man from talking to his family for years

Misophonia, a condition whereby certain sounds, particularly those made by another person can trigger emotions such as anger, impulsivity and a number of other responses.

Examples of these sounds include a crying baby, a clicking pen and chewing. A while ago, we asked readers on our Facebook page to tell us what they thought the most annoying sounds were and the most votes went to food sounds or loud chewing.

Image credit: iStock

Share Button